HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

China Healthcare Weekly (Nov.3) - TCM VBP Update, ADC CXO's Logic Is Solid, "Ugly Move" Of Innovent

Sino Biopharm (1177.HK) To Acquire Hob Biotech (688656.CH)- Time to Buy Hob and Sell Sino Biopharm?

China Healthcare Weekly (Nov.10)-Biotech Model Validation, CNPGC Need to Fulfill Commitment to Taiji

A Rare Surge in China's Stock Market - But, This Is Not a Bull Market

China Healthcare Weekly (Oct.6) - WuXi to Sell Assets, Be Rational on China CXO, Sihuan Underperform

CPMC Holdings (906.HK) Privatization Update - Will ORG Withdraw Midway?

Pre-IPO Sichuan Biokin Pharmaceutical - Would Investors Be Willing to Take a Gamble?

Thematic (Sector/Industry)

United states Financials / Thematic (Sector/Industry)

<ul>
<li>With the Fed starting to cut interest rate, the capital accumulation in US peaked and begins to enter a downward cycle.Then, the overall size of the US economy would shrink. </li>
<li>Before Nov.5 or even Christmas holiday, US asset prices (e.g. stock market) won’t have much trouble.But starting from next year, with a new president in office, things could get tricky.</li>
<li>Accompanying dollar depreciation is hyperinflation. Together with Middle East/Russia-Ukraine War, anything can happen. Investors may want to consider taking profits in Chinese stocks to make room for inflation trading later.</li>
</ul>


With the Fed starting to cut interest rate, the capital accumulation in US peaked and begins to enter a downward cycle.Then, the overall size of the US economy would shrink. 
Before Nov.5 or even Christmas holiday, US asset prices (e.g. stock market) won’t have much trouble.But starting from next year, with a new president in office, things could get tricky.
Accompanying dollar depreciation is hyperinflation. Together with Middle East/Russia-Ukraine War, anything can happen. Investors may want to consider taking profits in Chinese stocks to make room for inflation trading later.


2025 Capital Market Outlook (Part 1) - Take Profits in Stock Market and Switch to Inflation Trade